Redirecting to https://apnews.com/press-release/pr-newswire/hoth-therapeutics-delivers-100-clinical-response-with-50-reduction-in-disease-severity-in-open-label-pk-cohort-of-egfr-treated-cancer-patients-93e196271c3026ad471e710c77de1665